搜索此博客

2019年7月1日星期一

Finerenone 1050477-31-0 Sole GMP Manufacturer

Finerenone 1050477-31-0 Sole GMP Manufacturer

Finerenone 1050477-31-0 stable novel crystalline or amorphous form both we have, Finerenone 1050477-31-0no any IP problem. Finerenone 1050477-31-0 DMF filling, free sample of Finerenone 1050477-31-0.

EOS Med Chem have already carried out Finerenone 1050477-31-0 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Finerenone 1050477-31-0 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.

Below is Finerenone 1050477-31-0 Intermeidates list, most from GMP plant:

Finerenone 1050477-31-0, CAS 1050477-31-0 Intermediate,  21962-45-8, stock 1.9kg, assay 98.9%, White powder.
Finerenone 1050477-31-0, CAS 1050477-31-0 Intermediate,  1050477-39-8, stock 2kg, assay 98.7%, White powder.
Finerenone 1050477-31-0, CAS 1050477-31-0 Intermediate,  95306-64-2, stock 3.5kg, assay 98.1%, White powder.
Finerenone 1050477-31-0, CAS 1050477-31-0 Intermediate,  1050477-43-4, stock 7.6kg, assay 98.2%, White powder.
Finerenone 1050477-31-0, CAS 1050477-31-0 Intermediate,  1050477-44-5, stock 9kg, assay 98.2%, White powder.
Finerenone 1050477-31-0, CAS 1050477-31-0 Intermediate,  1050477-45-6, stock 8.1kg, assay 98.3%, White powder.
Finerenone 1050477-31-0, CAS 1050477-31-0 Intermediate,  1050477-27-4, stock 1.2kg, assay 98.4%, White powder.


Finerenone 1050477-31-0 HNMR, MASS, COA, MSDS we have.

Finerenone 1050477-31-0, free sample, welcome to ask:

2019 CHINA CPHI  E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.

R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com